Precision BioSearch Announced as Sponsor of Bio€quity Europe 2024
Precision BioSearch, a leading executive search partner specializing in the early-stage biotech sector, has announced its corporate sponsorship of Bio€quity Europe for a second consecutive year.
Precision BioSearch, sponsors of BIA UK Biotech Financing event
Precision BioSearch, a leading executive search partner to the early-stage biotech sector, is proud to announce its sponsorship of the BIA event, “UK Biotech Financing in 2024: A Year of Change and Opportunity”, held on 25th January 2024 at BMA House, London.
Our Co-founder, Malcolm Silander, presents at the OBN Awards 2023
Precision BioSearch was delighted to present Jonny Ohlson, Executive Chair and Founder, and Elena Stoyanova, Senior Scientist – New Technologies, of Touchlight with the award for ‘Best Established Biotech Company’ award at the OBN Awards 2023.
Precision BioSearch supports Pioneer Group’s ‘Launch Accelerator’ programme
Precision BioSearch Co-founder, Malcolm Silander, will deliver a half-day seminar to 14 Founders of the UK’s most exciting early-stage biotech companies as part of the Pioneer Group Launch Accelerator programme.
Myricx Bio partners with Precision BioSearch to appoint CSO
Precision BioSearch was delighted to partner with Myricx Bio, a biotech company focusing on the discovery and development of a completely novel class of selectively cytotoxic payloads for antibody-drug conjugates (ADCs), to secure the appointment of Dr Francesca Zammarchi as Chief Scientific Officer.
Hiring with precision: candidate behaviours in a post-boom market
Biotech investment has taken a considerable downward turn over the past 18 months, impacted by the global macroeconomic situation and a return to lower levels of funding post-pandemic.
Precision BioSearch expands C-suite team of SENISCA with COO and CDO appointments
Precision BioSearch partnered with SENISCA, an award-winning biotechnology company developing RNA based therapeutics to reverse cellular senescence and target age-related disease
‘How to be an early-stage Biotech CEO in challenging times’, cited by Citeline
Our Co-founder, Malcolm Silander, chaired the discussion which formed the basis of Andrew McConaghie’s (In Vivo / Citeline) recent article, ‘How to be an early-stage Biotech CEO in challenging times’.
Precision BioSearch, corporate sponsorship of Bio Equity Europe 2023
Precision BioSearch is delighted to announce our corporate sponsorship of Bio Equity Europe 2023, being held from May 14-16th in Dublin, Ireland.
NRG Therapeutics partners with Precision BioSearch to expand management team
Precision BioSearch was pleased to partner with NRG Therapeutics, an innovative neuroscience company targeting mitochondrial dysfunction, to secure Gilles Ouvry as VP Chemistry and Vad Lazari as VP Biology.